BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 20166872)

  • 1. The type I IFN system in rheumatoid arthritis.
    Conigliaro P; Perricone C; Benson RA; Garside P; Brewer JM; Perricone R; Valesini G
    Autoimmunity; 2010 Apr; 43(3):220-5. PubMed ID: 20166872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel role of plasmacytoid dendritic cells in humans: induction of interleukin-10-producing Treg cells by plasmacytoid dendritic cells in patients with rheumatoid arthritis responding to therapy.
    Kavousanaki M; Makrigiannakis A; Boumpas D; Verginis P
    Arthritis Rheum; 2010 Jan; 62(1):53-63. PubMed ID: 20039433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enumeration and phenotypical analysis of distinct dendritic cell subsets in psoriatic arthritis and rheumatoid arthritis.
    Jongbloed SL; Lebre MC; Fraser AR; Gracie JA; Sturrock RD; Tak PP; McInnes IB
    Arthritis Res Ther; 2006; 8(1):R15. PubMed ID: 16507115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoimmunity and bone.
    Schwarz EM; Looney RJ; Drissi MH; O'Keefe RJ; Boyce BF; Xing L; Ritchlin CT
    Ann N Y Acad Sci; 2006 Apr; 1068():275-83. PubMed ID: 16831928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type I interferons might form the link between Toll-like receptor (TLR) 3/7 and TLR4-mediated synovial inflammation in rheumatoid arthritis (RA).
    Roelofs MF; Wenink MH; Brentano F; Abdollahi-Roodsaz S; Oppers-Walgreen B; Barrera P; van Riel PL; Joosten LA; Kyburz D; van den Berg WB; Radstake TR
    Ann Rheum Dis; 2009 Sep; 68(9):1486-93. PubMed ID: 18765427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells.
    González MA; Gonzalez-Rey E; Rico L; Büscher D; Delgado M
    Arthritis Rheum; 2009 Apr; 60(4):1006-19. PubMed ID: 19333946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendritic cells in rheumatoid arthritis: Which subset should be used as a tool to induce tolerance?
    Lebre MC; Tak PP
    Hum Immunol; 2009 May; 70(5):321-4. PubMed ID: 19236901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dendritic cells and interferon-mediated autoimmunity.
    Gottenberg JE; Chiocchia G
    Biochimie; 2007; 89(6-7):856-71. PubMed ID: 17562353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dendritic cells and their potential implication in pathology and treatment of rheumatoid arthritis.
    Wenink MH; Han W; Toes RE; Radstake TR
    Handb Exp Pharmacol; 2009; (188):81-98. PubMed ID: 19031022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendritic cells from bench to bedside and back.
    Adema GJ
    Immunol Lett; 2009 Feb; 122(2):128-30. PubMed ID: 19121337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerogenic dendritic cells for autoimmune disease and transplantation.
    Thomson AW; Robbins PD
    Ann Rheum Dis; 2008 Dec; 67 Suppl 3():iii90-6. PubMed ID: 19022823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigen-specific suppression of established arthritis in mice by dendritic cells deficient in NF-kappaB.
    Martin E; Capini C; Duggan E; Lutzky VP; Stumbles P; Pettit AR; O'Sullivan B; Thomas R
    Arthritis Rheum; 2007 Jul; 56(7):2255-66. PubMed ID: 17599748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventing autoimmune arthritis using antigen-specific immature dendritic cells: a novel tolerogenic vaccine.
    Popov I; Li M; Zheng X; San H; Zhang X; Ichim TE; Suzuki M; Feng B; Vladau C; Zhong R; Garcia B; Strejan G; Inman RD; Min WP
    Arthritis Res Ther; 2006; 8(5):R141. PubMed ID: 16911769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IRF-7 is the master regulator of type-I interferon-dependent immune responses.
    Honda K; Yanai H; Negishi H; Asagiri M; Sato M; Mizutani T; Shimada N; Ohba Y; Takaoka A; Yoshida N; Taniguchi T
    Nature; 2005 Apr; 434(7034):772-7. PubMed ID: 15800576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendritic cell subsets: their roles in rheumatoid arthritis.
    Lebre MC; Tak PP
    Acta Reumatol Port; 2008; 33(1):35-45. PubMed ID: 18344920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances on the immunomodulatory effects of IFN-alpha: implications for cancer immunotherapy and autoimmunity.
    Rizza P; Moretti F; Belardelli F
    Autoimmunity; 2010 Apr; 43(3):204-9. PubMed ID: 20187707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigen-induced, tolerogenic CD11c+,CD11b+ dendritic cells are abundant in Peyer's patches during the induction of oral tolerance to type II collagen and suppress experimental collagen-induced arthritis.
    Min SY; Park KS; Cho ML; Kang JW; Cho YG; Hwang SY; Park MJ; Yoon CH; Min JK; Lee SH; Park SH; Kim HY
    Arthritis Rheum; 2006 Mar; 54(3):887-98. PubMed ID: 16508971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of myeloid dendritic cells and plasmacytoid dendritic cells in the synovial tissues of rheumatoid arthritis.
    Takakubo Y; Takagi M; Maeda K; Tamaki Y; Sasaki A; Asano T; Fukushima S; Kiyoshige Y; Orui H; Ogino T; Yamakawa M
    J Rheumatol; 2008 Oct; 35(10):1919-31. PubMed ID: 18785315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of interferon regulatory factor 3 in type I interferon responses in rotavirus-infected dendritic cells and fibroblasts.
    Douagi I; McInerney GM; Hidmark AS; Miriallis V; Johansen K; Svensson L; Karlsson Hedestam GB
    J Virol; 2007 Mar; 81(6):2758-68. PubMed ID: 17215281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type I interferon therapy and its role in autoimmunity.
    Biggioggero M; Gabbriellini L; Meroni PL
    Autoimmunity; 2010 Apr; 43(3):248-54. PubMed ID: 20298125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.